Report overview
Thoracic Endoprosthesis can be used for minimally invasive endovascular treatment of the descending branch of the thoracic aorta (including aneurysm, transection and all type B anatomy). It is characterized by optimized integration, patient adaptability, and strong clinical data.
This report contains market size and forecasts of Thoracic Endoprosthesis in global, including the following market information:
Global Thoracic Endoprosthesis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thoracic Endoprosthesis Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Thoracic Endoprosthesis companies in 2021 (%)
The global Thoracic Endoprosthesis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aorta Endoprosthesis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thoracic Endoprosthesis include W. L. Gore & Associates, Medtronic, PlasmaChem GmbH, Cordis Corporation, Boston Scientific and Lifetech Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Thoracic Endoprosthesis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thoracic Endoprosthesis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Thoracic Endoprosthesis Market Segment Percentages, by Type, 2021 (%)
Aorta Endoprosthesis
Branch Endoprosthesis
Global Thoracic Endoprosthesis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Thoracic Endoprosthesis Market Segment Percentages, by Application, 2021 (%)
Hospital
Outpatient Department
Surgical Diagnosis and Treatment Center
Other
Global Thoracic Endoprosthesis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Thoracic Endoprosthesis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thoracic Endoprosthesis revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thoracic Endoprosthesis revenues share in global market, 2021 (%)
Key companies Thoracic Endoprosthesis sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Thoracic Endoprosthesis sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
W. L. Gore & Associates
Medtronic
PlasmaChem GmbH
Cordis Corporation
Boston Scientific
Lifetech Scientific
